Clinical Significance of Roseomonas Species Isolated from Catheter and Blood Samples: Analysis of 36 Cases in Patients with Cancer

Do, Indra; Rolston, Kenneth V. I.; Han, Xiang V.
June 2004
Clinical Infectious Diseases;6/1/2004, Vol. 38 Issue 11, p1579
Academic Journal
This report analyzes 36 cases of bacteremia or catheter-related infection caused by Roseomonas species, a group of pink, slimy, waterborne, gram-negative coccobadihi. The causative species included the newly described Roseomonas mucosa (22 cases [61%]) and Roseomonas gilardii subspecies rosen (8 cases [22%]) and known species R. gilardii subspecies gilardii (5 cases [14%]) and Roseomonas genomospecies 4 (1 case [3%]). Twenty-nine (81%) of the cases were symptomatic, with fever being the most common symptom (in 27 [75%] of the cases). Twenty (56%) of the infections were monomicrobic. Six cases (17%) involved persistent catheter colonization, and 5 of these cases required removal of the catheter to clear the infection. All infections resolved, most with empirical antibiotic treatment. A summary of the antibiotic susceptibility pattern of these strains and other reported series show that Roseomonas species are consistently susceptible to amikacin and imipenem and frequently susceptible to ciprofloxacin and ticarcilhin, but essentially nonsusceptible to ceftazidime and cefepime. This result may guide future therapy for infections due to Roseomonas species.


Related Articles

  • Gatifloxacin. Perry, C.M.; Barman Balfour, J.A.; Lamb, H.M. // Drugs;Oct1999, Vol. 58 Issue 4, p683 

    â–´ Gatifloxacin is a novel extended-spectrum fluoroquinolone with improved Gram-positive and anaerobe coverage compared with older agents such as ciprofloxacin. It has good activity (but is slightly less active than ciprofloxacin) against Enterobacteriaceae. â–´ Gatifloxacin is...

  • A comparative trial of three therapeutic regimens: ciprofloxacin-rifampin, ciprofloxacin-doxycycline and doxycycline-rifampin in the treatment of brucellosis. Keramat, Fariba; Ranjbar, Mitra; Mamani, Mojgan; Hashemi, Seyyed Hamid; Zeraati, Fatemeh // Tropical Doctor;Oct2008, Vol. 39 Issue 4, p207 

    This study was designed to compare the efficacy of ciprofloxacin plus rifampin (CR) and ciprofloxacin plus doxycycline (CD) versus doxycycline plus rifampin (DR) in the treatment of brucellosis. A total of 178 patients with brucellosis who were referred to the Sina Hospital, Hamedan, Iran, were...

  • In vitro and in vivo evaluation of [18F]ciprofloxacin for the imaging of bacterial infections with PET. Langer, Oliver; Brunner, Martin; Zeitlinger, Markus; Ziegler, Sophie; Müller, Ulrich; Dobrozemsky, Georg; Lackner, Edith; Joukhadar, Christian; Mitterhauser, Markus; Wadsak, Wolfgang; Minar, Erich; Dudczak, Robert; Kletter, Kurt; Müller, Markus // European Journal of Nuclear Medicine & Molecular Imaging;Feb2005, Vol. 32 Issue 2, p143 

    Purpose: The suitability of the 18F-labelled fluoroquinolone antibiotic ciprofloxacin ([18F]ciprofloxacin) for imaging of bacterial infections with positron emission tomography (PET) was assessed in vitro and in vivo. Methods: For the in vitro experiments, suspensions of various E. coli strains...

  • Fluoroquinolone Susceptibility of Campylobacter Strains, Senegal. Cardinale, Eric; Dromigny, Jacques-Albert; Tall, Fatou; Ndiaye, Maguatte; Konte, Mamady; Perrier-Gros-Claude, Jean David // Emerging Infectious Diseases;Nov2003, Vol. 9 Issue 11, p1479 

    To assess fluoroquinolone susceptibility of Campylobacter strains in Senegal, skin samples were collected from 250 chicken carcasses from January 2001 to October 2002. Among 205 isolated Campylobacter strains, 59% and 41% were identified as Campylobacter jejuni and C. coli, respectively; the...

  • In vitro Antimicrobial Activity of Liposomes Containing Ciprofloxacin,Meropenem and Gentamicin Against Gram-Negative Clinical Bacterial Strains. Gubernator, Jerzy; Drulis-Kawa, Zuzanna; Dorotkiewicz-Jach, Agata; Doroszkiewicz, Wlodzimierz; Kozubek, Arkadiusz // Letters in Drug Design & Discovery;May2007, Vol. 4 Issue 4, p297 

    The antimicrobial activity of two cationic liposomes containing three antibiotics were tested in vitro. Ciprofloxacin loaded in liposomes exhibited a 2-4 times higher antimicrobial activity compared with the free drug. The bacterial sensitivity to liposomal meropenem were similar as to free...

  • Optimizing use of ciprofloxacin: a prospective intervention study. Babette C. van Hees; Erica de Ruiter; Ed H. Wiltink; Bartelt M. de Jongh; Matthijs Tersmette // Journal of Antimicrobial Chemotherapy (JAC);Jan2008, Vol. 61 Issue 1, p210 

    : Objectives Antimicrobial resistance to ciprofloxacin is increasing. The objective of this study was to reduce the number of inappropriate prescriptions and to improve the quality of ciprofloxacin prescriptions by means of educational intervention. : Methods In a teaching hospital five units...

  • Effect of GrlA mutation on the development of quinolone resistance in Staphylococcus aureus in an in vitro pharmacokinetic model. Yoshimi Oonishi; Junichi Mitsuyama; Keizo Yamaguchi // Journal of Antimicrobial Chemotherapy (JAC);Nov2007, Vol. 60 Issue 5, p1030 

    Objectives To investigate the effect of GrlA mutation on the development of quinolone resistance in Staphylococcus aureus in an in vitro pharmacokinetic (PK) model and to examine the relationship between the emergence of resistance and PK/pharmacodynamic parameters. Methods A wild-type and a...

  • Selection of quinolone resistance in Streptococcus pneumoniae exposed in vitro to subinhibitory drug concentrations. Laetitia Avrain; Mark Garvey; Narcisa Mesaros; Youri Glupczynski; Marie-Paule Mingeot-Leclercq; Laura J. V. Piddock; Paul M. Tulkens; Raymond Vanhoof; Françoise Van Bambeke // Journal of Antimicrobial Chemotherapy (JAC);Nov2007, Vol. 60 Issue 5, p965 

    Objectives Does exposure to subinhibitory concentrations of quinolones favour overexpression of efflux pumps or selection of target site mutations? Methods ATCC 49619 (fully susceptible) and SP32 (clinical isolate with PmrA-mediated efflux and mutation in ParE) were exposed for 24 h in broth to...

  • Legionella pneumonia caused by Legionella pneumophila serogroup 2: second case report in Japan. Makoto Furugen; Michio Koide; Motoo Baba; Yoko Sato; Hiromitsu Teruya; Yui Naha; Maki Tamayose; Morikazu Akamine; Teruhito Uchihara; Eriko Atsumi; Shusaku Haranaga; Satomi Yara; Futoshi Higa; Masao Tateyama; Jiro Fujita // Journal of Infection & Chemotherapy (Springer Science & Business;Apr2008, Vol. 14 Issue 2, p161 

    Abstract  A 56-year-old man with a 3-day history of a chilly sensation and general fatigue presented to a hospital in his neighborhood. He was diagnosed as having pneumonia and immediately treated with intravenous ceftriaxone sodium, but his respiratory condition deteriorated and he...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics